Cerevel Therapeutics

Developer of therapeutics for neurological and neuropsychiatric disorders

placeBoston, Massachusetts, United States calendar_todayFounded 2018 groups199 employees language cerevel.com

Registered entities

Innovation

6 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 165 times.

YearFilings
20243
20253
20263

Investor mix

7 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital229%
Private equity457%
Other / undisclosed114%
Coming soon